Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Nephron Pharmaceuticals Corporation Invests US$215m in New Projects in Lexington County
Nephron Pharmaceuticals Corporation has announced major investment plan in Lexington County, where it is headquartered, with an investment of US$215 million
SEKISUI Diagnostics Invests US$ 18.6 million in cGMP Microbial Capacity Expansion
Sekisui Diagnostics announced its plans to invest US$ 186 million 144 million in biopharma CDMO business to expand cGMP microbial capacity located at its existing site in Maidstone
SCA Pharma to Build a New Production Facility in Little Rock
SCA Pharma announced its plans to expand operations with the construction of a new production facility in Little Rock, with an investment of over US$10 million, which includes renovation of the existing facility and building a new facility
Emergent BioSolutions Invests US$75 million in New Manufacturing Unit
Emergent BioSolutions has announced US$75 million investment plan to expand viral vector and gene therapy capabilities in its facility at Canton, Massachusetts This investment is part of the companys bid to strengthen its Contract Development
Fujifilm Invests US$83m to Expand Biotechnologies Microbial Capacity in UK
FUJIFILM Corporation plans to invest US$83 million dollars to expand microbial production capacity of FUJIFILM Diosynth Biotechnologies FDB
FUJIFILM Diosynth Biotechnologies to Construct New Biocampus in UK
FUJIFILM Diosynth Biotechnologies FDBunveiled its plans for the construction of a new US$1905m 145m BioCampus at Billingham, UK
Thermo Fisher Opens New Commercial Manufacturing Site in Plainville, USA
Thermo Fisher Scientific Inc, has recently announced its plans to expand its facility for increasing capacity of viral vector development and manufacturing services located
Sanofi to Build a New World Class Research Centre
Sanofi plans to build a world class vaccine production site and a new research centre dedicated for the development of vaccines with an investment of 610 million
Evonik Expands Dossenheim and Hanau Sites in Germany
Evonik has announced plans for the expansion of its Dossenheim and Hanau facilities in Germany in order to meet the increasing pharmaceutical demand for contract manufacturing
Klöckner Pentaplast Builds Klöckner Barrier Film (KBF) Facility
Klckner Pentaplast plans to expand its Klckner Barrier Film KBF facility, located in central Virginia in the United States Through this expansion, the company intendsto support the growing pharmaceuticals market
